Enanta Pharmaceuticals
ENTA
#7360
Rank
S$0.57 B
Marketcap
S$19.89
Share price
5.92%
Change (1 day)
149.32%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$0.27 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are S$0.27 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30S$0.31 B-5.05%
2023-09-30S$0.33 B332.14%
2022-09-30S$77.62 M45.19%
2021-09-30S$53.46 M28.23%
2020-09-30S$41.69 M10.35%
2019-09-30S$37.78 M34.49%
2018-09-30S$28.09 M-17.18%
2017-09-30S$33.92 M119.26%
2016-09-30S$15.47 M10.28%
2015-09-30S$14.03 M62.64%
2014-09-30S$8.62 M5.65%
2013-09-30S$8.16 M-19.3%
2012-09-30S$10.11 M88.07%
2011-09-30S$5.38 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AbbVie
ABBV
S$176.42 B 63,088.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$146.74 B 52,460.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$9.74 B 3,392.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$100.34 B 35,841.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$101.18 B 36,142.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$80.82 B 28,850.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland